Shuho issue 639 interviews Linda Summerton, Ph.D., the CEO of Immodulon Therapeutics Ltd., about triggering the immune system to fight cancer with mycobacteria.
MSA Partners recently released a new report, “Ushering in the Age of Biosimilars.” The report dertails the FDA’s draft guidelines for biosimilar approval, the status of biosimilars in Europe, and industry activities.
Research & Consulting
The cornerstone of any successful business is intelligence. MSA researches markets, industry trends, regulatory policies, and public sentiment to provide evidence-based information and clear guidance.
Building off its research expertise, MSA helps its clients successfully position themselves in the market. MSA offers outreach, liaison, point, and principal services.. -----»
MSA helps clients target their messages to key external and internal audiences. Fully bilingual, MSA works with clients to optimize communication between their offices in the US and Japan.